What is the recommended workup and management strategy for dementia in an older adult, including assessment of reversible causes and pharmacologic therapy?

Dementia Workup and Management

For older adults presenting with dementia, conduct a comprehensive assessment that includes screening for reversible causes (medications, sleep disorders, hearing impairment, and metabolic conditions), followed by implementation of evidence-based non-pharmacologic interventions as first-line therapy, with cholinesterase inhibitors reserved for mild-to-moderate Alzheimer's disease on an individual risk-benefit basis. 1

Initial Assessment and Reversible Causes

Medication Review

• Immediately review and minimize anticholinergic medications, which are a common reversible cause of cognitive impairment in older adults 1
• Conduct multidimensional health assessment specifically targeting medication rationalization to identify modifiable conditions 1
• Common culprits include medications for depression, neuropathic pain, and urinary incontinence—substitute with non-anticholinergic alternatives 1

Sleep Evaluation

• Obtain detailed sleep history assessing total sleep time, insomnia, daytime sleepiness, napping patterns, and REM sleep behavior disorder 1
• Refer patients with suspected sleep apnea for polysomnography and sleep specialist consultation 1
• Treat confirmed sleep apnea with CPAP, which may improve cognition and decrease dementia risk 1
• Target 7-8 hours of sleep nightly while avoiding severe sleep deprivation (<5 hours) 1

Sensory Assessment

• Screen for hearing impairment by asking if the patient has difficulty hearing in everyday life (rather than asking if they have hearing loss) 1
• If hearing symptoms are present, confirm with formal audiometry and provide audiologic rehabilitation including hearing aids when indicated 1
• Assess and correct vision impairment, as correction may improve cognitive functioning 1

Neuropsychiatric Symptoms

• Use validated informant-rated scales like the Neuropsychiatric Inventory (NPI-Q) or Mild Behavioural Impairment Checklist (MBI-C) to operationalize assessment 1
• Consider memory clinic referral for later-life emergent and sustained neuropsychiatric symptoms requiring additional workup 1

Additional Reversible Causes

• Screen for depression, delirium, and systemic medical conditions that may contribute to cognitive impairment 2, 3
• Approximately 10-20% of dementia evaluations will uncover a treatable underlying cause 2, 3

Non-Pharmacologic Management (First-Line)

Physical Exercise

• Prescribe aerobic exercise and/or resistance training of at least moderate intensity for all patients with dementia or MCI 1
• Physical activity interventions reduce dementia risk and improve cognitive outcomes in established disease 1
• Consider dance interventions or mind-body exercises (Tai Chi, Qigong) as alternatives, though evidence is less robust 1

Cognitive Interventions

• Recommend group cognitive stimulation therapy for mild-to-moderate dementia, which provides enjoyable activities for thinking, concentration, and memory in social settings 1
• Encourage computer-based and group cognitive training for at-risk individuals and those with MCI or mild dementia 1
• Advise patients to increase engagement in cognitively stimulating activities including hobbies, volunteering, and lifelong learning 1

Nutritional Modifications

• Recommend adherence to a Mediterranean diet to decrease cognitive decline risk 1
• Increase consumption of mono- and polyunsaturated fatty acids while reducing saturated fat intake 1
• Increase fruit and vegetable consumption 1

Caregiver Support

• Provide psychosocial and psychoeducational interventions for caregivers, including education, counseling, problem-solving strategies, and information about services 1
• These interventions help caregivers develop both problem-focused and emotion-focused coping strategies 1

Social Engagement

• Address social circumstances and support opportunities for social engagement throughout the disease course 1
• Support educational attainment and ongoing educational experiences in mid and later life 1

Pharmacologic Management

Cholinesterase Inhibitors

• Prescribe cholinesterase inhibitors (donepezil, rivastigmine, or galantamine) for mild-to-moderate Alzheimer's disease based on individual risk-benefit assessment 4, 5
• These are the only FDA-approved treatments for Alzheimer's disease and demonstrate moderate benefits in cognitive, behavioral, and functional domains 4
• Donepezil, rivastigmine, and galantamine are preferred over tacrine due to lack of hepatotoxicity, ease of administration, and fewer drug interactions 4

Administration Considerations

• Start with gradual dose increases and administer with food to minimize gastrointestinal side effects (nausea, vomiting, diarrhea, anorexia) 4
• Use caution in patients with severe liver disease, preexisting bradycardia, peptic ulcer disease, asthma, or COPD 4
• Known hypersensitivity is the only absolute contraindication 4

Vitamin E

• Consider high-dose vitamin E (1000 IU twice daily) in addition to cholinesterase inhibitors, as it may slow AD progression and has low cost with favorable safety profile 4

Behavioral Symptoms

• Use non-pharmacologic approaches first for mild mood and behavioral concerns before considering pharmacotherapy 5

Important Caveats

• No specific exercise duration, intensity, or cognitive training program can be definitively endorsed at this time, though moderate intensity is recommended 1
• Evidence for cholinesterase inhibitors in dementia with Lewy bodies and vascular dementia is limited, though early reports suggest potential benefit in mixed dementia 4
• Frailty management interventions should be implemented to reduce overall dementia burden 1
• While insomnia, long sleep time, and circadian irregularities are associated with dementia, insufficient evidence exists to recommend specific treatments for dementia prevention 1